Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026)

Nexalin Technology (NXL) recorded quarterly Cash from Financing Activities of $756421.0 in Q1 2026, up 44.48% quarter-over-quarter from $523550.0 in Q4 2025.

Nexalin Technology (NXL) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Nexalin Technology's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $756421.0 for Q1 2026.

  • In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $756421.0; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $5.2 million, up 14.48% from the prior year.
  • Cash from Financing Activities was $756421.0 for Q1 2026 at Nexalin Technology, up from $523550.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $8.5 million in Q3 2022 to a low of -$200000.0 in Q1 2023.
  • Historically, Cash from Financing Activities has averaged $1.6 million across 4 years, with a median of $261825.0 in 2022.
  • Biggest YoY gain for Cash from Financing Activities was 200100.0% in 2023; the steepest drop was 200100.0% in 2023.
  • A 4-year view of Cash from Financing Activities shows it stood at $8.5 million in 2022, then sank by 102.35% to -$200000.0 in 2023, then surged by 361.78% to $523550.0 in 2025, then soared by 44.48% to $756421.0 in 2026.
  • The last three Cash from Financing Activities figures came in at $756421.0 (Q1 2026), $523550.0 (Q4 2025), and -$200000.0 (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 17.31 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -1.51 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -451.20 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 21.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -25.00 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -97.90 Mn
10 Nexalin Technology 8.72 Mn 6.01 Mn 13,133.00 756,421.00

Historic Data

Download Data
DateValue
Mar 31, 2026 756,421.00
Mar 31, 2026 756,421.00
Dec 31, 2025 523,550.00
Dec 31, 2025 523,550.00
Mar 31, 2023 -200,000.00
Mar 31, 2023 -200,000.00
Sep 30, 2022 8.52 Mn
Sep 30, 2022 8.52 Mn
Jun 30, 2022 -5,000.00
Jun 30, 2022 -5,000.00
Mar 31, 2022 100.00
Mar 31, 2022 100.00
Dec 31, 2021 934,443.00
Dec 31, 2021 934,443.00